A61L15/42

Process for producing low endotoxin chitosan

The present invention relates to a process for producing a low endotoxin alkali chitosan, chitin, chitosan derivative or chitin derivative, and also to a process for producing low endotoxin neutral chitosan, chitosan salt and chitosan derivatives, and to the products of such processes. The process comprises contacting chitosan, chitin, chitosan derivative or chitin derivative with an alkali solution having a concentration of less than 0.25M to form a mixture; leaving the mixture for a period of less than 12 hours and optionally drying the mixture. The low endotoxin alkali chitosan may be used in the manufacture of other useful chitosan based products.

Process for producing low endotoxin chitosan

The present invention relates to a process for producing a low endotoxin alkali chitosan, chitin, chitosan derivative or chitin derivative, and also to a process for producing low endotoxin neutral chitosan, chitosan salt and chitosan derivatives, and to the products of such processes. The process comprises contacting chitosan, chitin, chitosan derivative or chitin derivative with an alkali solution having a concentration of less than 0.25M to form a mixture; leaving the mixture for a period of less than 12 hours and optionally drying the mixture. The low endotoxin alkali chitosan may be used in the manufacture of other useful chitosan based products.

Biotechnologically-produced cellulose-containing article for dermatological use
11529433 · 2022-12-20 · ·

A cellulose-containing article for treating an area of skin, wherein the article comprises BNC in an amount of at least 1% by weight and at most 15% by weight, comprises fluid in an amount of at least 85% by weight and at most 99% by weight, has an average thickness of at least 0.5 mm and at most 8 mm, wherein the BNC is of microbial origin.

Dressings With Polymer Delivery

Dressings and kits for use in wound therapy and negative-pressure therapy comprising a manifold layer comprising porous open-cell liquid permeable foam and a polymer composition The polymer composition comprises a polymer and an active agent, such as collagen and oxidized regenerated cellulose. The foam may be felted. Methods of making and using the dressings are also provided.

SINGLE USE, TOPICAL, HYDROPHILIC ARTICLE WITH A HEMOSTATIC FOAM
20220387659 · 2022-12-08 ·

A hemostatic surface application device having a region of hemostatic foam for contact with a patient's skin where a wound exists or is created, the device includes: a release layer, the release layer in contact with a hemostatic flexible foam section, and a structural foam layer having a front side and a back side surrounding the hemostatic flexible foam layer, forming a generally central hemostatic surface exposed through the front side of the surrounding structural foam layer, and a support layer adhered to the backside of the structural foam layer.

Foam compositions, foam matrices and methods

Disclosed herein are matrices, compositions and methods of making matrices. The matrix comprises a biomolecule and the matrix is a dried, cross-linked foam. The matrix is not lyophilized. The method comprises foaming the composition, crosslinking the composition and drying the composition. Matrices disclosed herein are useful as wound dressings and treating wounds.

VIOLACEIN-POLYMER COMPOSITE NANOFIBROUS MEMBRANE HAVING ANTIMICROBIAL EFFICACY AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS, AND MANUFACTURING METHOD THEREFOR

Embodiments of the present disclosure relate to a violacein-polymer composite nanofibrous antimicrobial membrane and a method for manufacturing same, wherein the membrane comprises violacein having antimicrobial efficacy against methicillin-resistant Staphylococcus aureus (MRSA) caused by resistance to antibiotics and is formed such that one-dimensional nanofibers are three-dimensionally entangled, and can be used as an antimicrobial membrane for preventing and treating MRSA infections. Specifically, a solution in which violacein is uniformly mixed is prepared by dissolving a large amount of violacein in a solution with a polymer dissolved therein, and the solution is subjected to an electrospinning process to synthesize a nanofibrous membrane in which violacein is uniformly included inside/outside nanofibers without agglomeration. Thus, this is different from existing methods for applying a material to the surface of fibers.

BIOMIMETIC WOUND DRESSING WITH ARTICULATING MICROPATTERN
20220378622 · 2022-12-01 ·

A surface is covered with microstructures that extend from the surface, and are made of a resilient material that allows the microstructures to bend or articulate. The microstructures are generally columnar and can have fingers on their distal or top end that is opposite the base from which the microstructures extend. In addition to the ordinary roughness presented by the microstructures, the articulation further discourages biofouling and bioadherence. The articulation of the microstructures can be oriented, and the orientations can be mixed or varied among the microstructures so that adjacent ones of the microstructures have different orientations of articulation.

BIOMIMETIC WOUND DRESSING WITH ARTICULATING MICROPATTERN
20220378622 · 2022-12-01 ·

A surface is covered with microstructures that extend from the surface, and are made of a resilient material that allows the microstructures to bend or articulate. The microstructures are generally columnar and can have fingers on their distal or top end that is opposite the base from which the microstructures extend. In addition to the ordinary roughness presented by the microstructures, the articulation further discourages biofouling and bioadherence. The articulation of the microstructures can be oriented, and the orientations can be mixed or varied among the microstructures so that adjacent ones of the microstructures have different orientations of articulation.

INJECTABLE AND MOLDABLE TISSUE-MIMETIC ELASTOMERS AND METHODS RELATED THERETO

Materials and methods related to elastomers are disclosed. The disclosed elastomers are useful in implants mimicking soft tissue. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.